Ipilimumab vs Sumatriptan
Ipilimumab vs Sumatriptan: Overview
This comparison examines the pharmacological differences between Ipilimumab and Sumatriptan.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Sumatriptan: Selective 5-HT1B/1D receptor agonist.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Sumatriptan — 2.5 hours.
Chemical Properties
Molecular Formula: Sumatriptan — C14H21N3O2S.
Molecular Weight: Sumatriptan — 295.4020 g/mol.
Type: Ipilimumab — Antibody; Sumatriptan — Small molecule.